St. Davids, PA, United States of America

Sriram Krishnaswamy

This inventor holds 2 USPTO granted patents. Top assignees: The Children's Hospital of Philadelphia, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2012-2015.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2012-2015

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Sriram Krishnaswamy: Innovator in Hemostasis Modulation

Introduction

Sriram Krishnaswamy is a notable inventor based in St. Davids, PA (US). He has made significant contributions to the field of hemostasis modulation, holding 2 patents that showcase his innovative work. His research focuses on developing novel thrombin/prothrombin protease/zymogen variants with anticoagulation activity.

Latest Patents

His latest patents include compositions and methods for modulating hemostasis. These patents disclose novel thrombin/prothrombin protease/zymogen variants that possess anticoagulation activity and methods of use thereof. This work is crucial for advancing medical treatments related to blood coagulation.

Career Highlights

Throughout his career, Sriram has worked with esteemed organizations such as the United States of America, as represented by the Secretary, Department of Health and Human Services, and The Children's Hospital of Philadelphia. His experience in these institutions has allowed him to contribute significantly to medical research and innovation.

Collaborations

Sriram has collaborated with notable coworkers, including Elsa P. Bianchini and Steven J. Orcutt. These partnerships have further enriched his research and development efforts in the field of hemostasis.

Conclusion

Sriram Krishnaswamy's work in hemostasis modulation exemplifies the impact of innovative research in medicine. His patents and collaborations highlight his commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…